Interactions between growth factor receptors and corresponding monoclonal antibodies in human tumors.
Monoclonal antibodies (MAbs) to the human epidermal growth factor (EGF) receptor, the type I insulin-like growth factor (IGF) receptor, and the nerve growth factor (NGF) receptor were used to study the growth regulation of malignant cells. Anti-EGF receptor MAb 425 inhibited the growth of A 431 squamous carcinoma cells which express high numbers of EGF receptors on their surfaces. Growth inhibition induced by MAb 425 was accompanied by alterations of the cell-cycle distribution of these cells, indicating the ability of a monoclonal antibody to act as a biologically active ligand. Growth stimulation of melanoma cells by EGF was unrelated to EGF receptor expression on the cell surface. Insulin- and IGF-I-induced growth stimulation of melanoma cells was inhibited by MAb alpha IR-3 which reacts with the type I IGF receptor. This result indicates that the type I IGF receptor mediated growth stimulation not only by IGF-I but also by insulin. Normal melanocytes and cells of all stages of tumor progression expressed in tissue culture the receptor for NGF, but no effect on the growth of these cells has been observed.
Rodeck
U
U
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.
Herlyn
M
M
Koprowski
H
H
D000911:Antibodies, Monoclonal; D002461:Cell Line, Transformed; D066246:ErbB Receptors / Q000276:immunology*; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D011863:Radioimmunoassay; D011972:Receptor, Insulin / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D017475:Receptors, Nerve Growth Factor; D017451:Receptors, Somatomedin
D000911:Antibodies, Monoclonal; D007328:Insulin; D011956:Receptors, Cell Surface; D017475:Receptors, Nerve Growth Factor; D017451:Receptors, Somatomedin; D066246:ErbB Receptors; D011972:Receptor, Insulin